Novartis Won’t Move Swiss Research Jobs, Jimenez Tells NZZ

Novartis AG (NOVN), which is investing $1 billion to build a research and development center in Shanghai, won’t move highly-qualified jobs away from Switzerland, Chief Executive Officer Joe Jimenez told NZZ am Sonntag.

The company wants to tap the “enormous supply of talent” in China, Jimenez told the newspaper in an interview.

To contact the reporters on this story: Elena Logutenkova in Zurich at

To contact the editors responsible for this story: Frank Connelly at;

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.